Mast cell deficiency improves cognition and enhances disease-associated microglia in 5XFAD mice

Cell Rep. 2023 Sep 26;42(9):113141. doi: 10.1016/j.celrep.2023.113141. Epub 2023 Sep 19.

Abstract

Emerging evidence suggests that peripheral immune cells contribute to Alzheimer's disease (AD) neuropathogenesis. Among these, mast cells are known for their functions in allergic reactions and neuroinflammation; however, little is known about their role in AD. Here, we crossed 5XFAD mice with mast cell-deficient strains and observed the effects on AD-related neuropathology and cognitive impairment. We found that mast cell depletion improved contextual fear conditioning in 5XFAD mice without affecting cued fear conditioning, anxiety-like behavior, or amyloid burden. Furthermore, mast cell depletion led to an upregulation of transcriptomic signatures for putatively protective disease-associated microglia and resulted in reduced markers indicative of reactive astrocytes. We hypothesize a system of bidirectional communication between dural mast cells and the brain, where mast cells respond to signals from the brain environment by expressing immune-regulatory mediators, impacting cognition and glial cell function. These findings highlight mast cells as potential therapeutic targets for AD.

Keywords: 5XFAD; Alzheimer's disease; CP: Immunology; CP: Neuroscience; astrocyte; behavior; mast cell; meninges; microglia; neuroimmune interaction.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Alzheimer Disease* / pathology
  • Animals
  • Cognition
  • Immunologic Factors
  • Mast Cells / pathology
  • Mice
  • Mice, Transgenic
  • Microglia* / pathology

Substances

  • Immunologic Factors